Purixan

Product manufactured by Nova Laboratories, Ltd

Application Nr Approved Date Route Status External Links
NDA205919 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Purixan Is A Nucleoside Metabolic Inhibitor Indicated For The Treatment Of Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen.( 1.1 ) 1.1 Acute Lymphoblastic Leukemia Purixan Is Indicated For The Treatment Of Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mercaptopurine MERCAPTOPURINE ZINC4658290

Comments